For: | Ward JA, Yerke J, Lumpkin M, Kapoor A, Lindenmeyer CC, Bass S. Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy. World J Hepatol 2023; 15(11): 1226-1236 [PMID: 38075005 DOI: 10.4254/wjh.v15.i11.1226] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v15/i11/1226.htm |
Number | Citing Articles |
1 |
Chien-Hao Huang, Piero Amodio. Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment?. World Journal of Hepatology 2024; 16(2): 115-119 doi: 10.4254/wjh.v16.i2.115
Abstract(162) |
Core Tip(129) |
Full Article(HTML)(1035)
|
Full Article with Cover (PDF)-875K(42)
|
Full Article (Word)-129K(11)
|
Audio-162K(0)
|
Peer-Review Report-172K(14)
|
Answering Reviewers-129K(13)
|
Full Article (PDF)-363K(39)
|
Full Article (XML)-64K(22)
|
Times Cited (0)
|
Total Visits (2342)
|
Open
|